MYB and colorectal carcinoma: Transcription via p300-CREB enhanced oxaliplatin resistance in CRC by upregulation of the ABC transporter multidrug resistance-associated protein 2 (MRP2), while p300-MYB was more involved in gastrointestinal differentiation[52].